Form D · Other Technology

Oncology Analytics, Inc.

Atlanta, GA · CIK 0001664478

Offering snapshot reported May 15, 2020 · SEC filing

Reported sold
$25M
Offering amount: $28M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 30, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 15, 2020Initial$24,999,998No comparison7SEC filing
Nov 7, 2018Initial$20,999,997No comparison4SEC filing
Jan 28, 2016Initial$7,500,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-367091

Source: Form D, filed May 15, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Peter Bach Director
John Bradburn Director
Rick J. Dean Director, Executive
Zeke Emanuel Director
Marc Fishman Director, Executive
Danielle Fishman Executive
Thomas Hawes Director
Ann Lamont Director
Michael Liang Director
Marc Lippman Director
Dipa Mehta Director
Michael Montijo Director
Nick Rosa Director
Balbino Vazquez Director, Executive
Robert Walton Executive
Michael Weintraub Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
7000 Central Parkway Suite 1750
Atlanta, GA, 30328